Japan Medical Second Opinion Market Research Report By Application Outlook (Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, Respiratory Disorders, Ocular Disorders), By Source of Service Outlook (In-House, Outsourced), By Services Outlook (Medical Condition Management, Post-Acute Care Nursing, Medical Peer Review Services) and By Type Outlook (Hospitals Physicians/Specialties, Online Physicians Portal, Medical Second Opinion Companies, Health Insurance Companies) - Forecast to 2035

Japan Medical Device Second Opinion Market Overview

As per MRFR analysis, the Japan Medical Device Second Opinion Market Size was estimated at 0.18 (USD Billion) in 2023.The Japan Medical Device Second Opinion Market Industry is expected to grow from 0.21(USD Billion) in 2024 to 0.92 (USD Billion) by 2035. The Japan Medical Device Second Opinion Market CAGR (growth rate) is expected to be around 14.31% during the forecast period (2025 - 2035).

Key Japan Medical Device Second Opinion Market Trends Highlighted

The Japan Medical Device Second Opinion Market is shaped by several prominent trends driven by the need for enhanced patient safety and treatment efficacy. A significant market driver is the increasing prevalence of chronic diseases in Japan, which propels patients to seek additional confirmations of diagnoses and treatment options beyond their primary healthcare providers. The aging population in Japan further intensifies this demand, as older individuals often require more complex medical care, thereby increasing the relevance of obtaining second opinions regarding medical devices and treatments. Opportunities for growth in this market can be explored through the integration of digital health technologies, including telemedicine platforms that allow access to specialized medical experts remotely.

These advancements are particularly valuable in rural areas where access to expert opinions can be limited. Additionally, the government promotes healthcare reforms that encourage transparent medical practices and the sharing of information, which can fuel trust in obtaining second opinions and utilizing advanced medical devices. Recent trends also reflect a growing awareness among patients regarding their rights to seek multiple opinions and to make informed decisions about their health. There is an increase in patient engagement facilitated by online resources and community forums, empowering individuals to advocate for themselves in the medical process.Furthermore, collaborations between hospitals and technology firms are on the rise, supporting innovations in medical devices and ensuring that patients are referred to the most suitable specialists for second opinions. These dynamics contribute to the evolving landscape of the Japan Medical Device Second Opinion Market, underscoring the necessity for medical professionals to adapt to these changing consumer expectations and healthcare practices.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Japan Medical Device Second Opinion Market Drivers

Rising Demand for Accurate Diagnosis

The Japan Medical Device Second Opinion Market Industry is witnessing a significant increase in demand for accurate diagnosis primarily due to the rising complexities associated with medical conditions. As per recent data from the Japanese Ministry of Health, Labour and Welfare, healthcare professionals in Japan are facing an average diagnostic error rate of approximately 10%. This has prompted patients and healthcare providers to seek second opinions to ensure the prescribed treatment is suitable.The Japanese government has also launched initiatives encouraging collaboration among healthcare providers to enhance diagnostic accuracy, further supporting the growth of the second opinion market. Established hospitals like Tokyo Medical University Hospital are paving the way by integrating second opinion services into their patient care model, making them essential players in boosting the awareness and utilization of these services. This trend aligns with the growing inclination toward personalized medicine and precision health, driving further growth in the Japan Medical Device Second Opinion Market.

Increase in Chronic Diseases

The incidence of chronic diseases in Japan is significantly contributing to the growth of the Japan Medical Device Second Opinion Market Industry. Statistics from the Japan Health Promotion and Disease Prevention Association indicate that chronic conditions, such as diabetes and cardiovascular diseases, affect over 30% of the Japanese population. The complexity of managing these diseases often necessitates various medical opinions and advanced diagnostic equipment to ensure proper treatment pathways.Furthermore, the need for specialized devices, particularly in geriatric care, escalates as Japan ages rapidly, with forecasts indicating that by 2025, one in three citizens will be over 65 years old. Companies such as Olympus Corporation are advancing their medical devices to support this demographic, enhancing their relevance in the second opinion process thus propelling market growth.

Advancements in Telemedicine

The development and adoption of telemedicine are significantly shaping the landscape of the Japan Medical Device Second Opinion Market Industry. According to Japan's Ministry of Internal Affairs and Communications, there was a 250% surge in telemedicine consultations during the COVID-19 pandemic, reflecting a permanent shift in how healthcare services are delivered. The convenience and accessibility of virtual consultations enable patients to seek second opinions from specialists across the country without geographical constraints, enhancing their healthcare options.Such investments are creating favorable conditions for companies like Fujitsu and NEC, which concentrate on developing secure telehealth service platforms in Japan. These tell services foster an ecosystem that is friendly to second opinions, which enables the Japan Medical Device Second Opinion Market to grow rapidly and appeal to more users.

Growing Awareness of Patient Rights

There is a notable increase in awareness among Japanese citizens regarding patient rights, which is actively contributing to the Japan Medical Device Second Opinion Market Industry. According to the Consumer Affairs Agency, 76% of adults are primarily concerned about receiving the best possible medical care, leading to heightened calls for second opinions on critical health issues. This awareness is coupled with public campaigns aimed at educating citizens about their rights in healthcare settings, effectively promoting the importance of seeking additional medical perspectives, particularly for severe or chronic conditions.Notable organizations, including the Japanese Society of Medical Ethics, have been influential in fostering a culture of transparency and patient empowerment. As patients become more informed and proactive regarding their health decisions, the demand for medical device second opinions is expected to grow, further driving the market in Japan.

Japan Medical Device Second Opinion Market Segment Insights

Medical Device Second Opinion Market Application Outlook Insights

The Application Outlook for the Japan Medical Device Second Opinion Market reveals a robust structure focused on various health concerns that have an increasingly significant impact on the population. The healthcare landscape in Japan is heavily influenced by an aging demographic, with the elderly population projected to grow, thereby increasing the prevalence of chronic diseases such as cancer, diabetes, and cardiac disorders. The Cancer segment plays a pivotal role in this market as Japan has one of the highest cancer incidences globally, leading to a substantial demand for advanced diagnostic tools and opinion services that can improve treatment pathways. Similarly, diabetes has emerged as a major public health issue in Japan. With rising lifestyle-related factors contributing to the increasing rate of diabetes, the demand for medical devices providing accurate evaluations and second opinions is expected to grow.

Cardiac disorders also dominate the market due to Japan's high prevalence of heart-related issues, prompting a keen interest in innovative medical devices that can facilitate precise diagnostics and enhance patient outcomes. Neurological disorders, on the rise due to demographic factors and lifestyle changes, further emphasize the necessity for second opinions in treatment, as they often require specialized knowledge and cutting-edge medical technology to ensure effective management. The rising trend in telemedicine integrations is also noteworthy as it allows for remote second opinions, expanding access to expert medical evaluations across Japan's geographically diverse regions.Respiratory disorders have become increasingly prominent, particularly in an urbanized society where pollution and lifestyle factors contribute to respiratory challenges. 

The market for relevant medical devices is poised for growth as additional solutions are needed to provide comprehensive second opinions on treatment strategies. Ocular disorders likewise necessitate attention, given the increase in visual impairments due to the aging population and the heavy screen usage associated with modern lifestyles. As this segment diversifies, the demand for second opinion services to guide critical decisions regarding treatment methodologies will become essential in improving patient care. Overall, the Japan Medical Device Second Opinion Market segmentation, which focuses on these critical health issues, signifies a promising landscape with considerable opportunities amid continual advancements in technology and a growing need to enhance healthcare delivery in the region.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Medical Device Second Opinion Market Source of Service Outlook Insights

The Source of Service Outlook segment of the Japan Medical Device Second Opinion Market is poised to play a crucial role in the healthcare landscape, addressing the growing need for reliable medical insight and expertise. In Japan, where the demand for advanced medical devices and accurate second opinions is surging, two main service sources emerge: In-House and Outsourced solutions. In services are often favored by healthcare institutions aiming for consistent quality control and localized expertise. This is particularly significant in Japan, given the country's stringent healthcare regulations and the high level of trust patients place in local healthcare providers.On the other hand, Outsourced services are gaining traction as they allow healthcare facilities to tap into a broader network of specialists, thereby enhancing patient care through diverse insights and experiences. The increasing complexity of medical technologies and the rapid evolution of the healthcare industry further support the significance of these service sources as healthcare practitioners strive to provide the best outcomes for patients. Thus, the Japan Medical Device Second Opinion Market segmentation showcases a dynamic interplay between In-House and Outsourced services, reflecting a robust response to the evolving needs of the healthcare sector.

Medical Device Second Opinion Market Services Outlook Insights

The Japan Medical Device Second Opinion Market is demonstrating noteworthy growth within the Services Outlook segment, largely driven by increasing demand for enhanced healthcare solutions. Medical Condition Management is pivotal in this context, as it facilitates ongoing patient care and supports long-term health outcomes. Meanwhile, Post-Acute Care Nursing plays a crucial role in ensuring patients transition smoothly from hospital to home, emphasizing personalized care that caters to individual recovery needs, thereby enhancing patient satisfaction and reducing readmissions.Additionally, Medical Peer Review Services serve as a vital component, establishing quality assurance in medical practices through expert evaluations. The market's adaptability to evolving healthcare technologies and the emphasis on collaborative treatment strategies highlight substantial opportunities for growth in Japan. As the country continues to address its aging population and rising chronic disease prevalence, the Services Outlook segment remains integral, contributing to the overall advancement of healthcare delivery and patient management within the Japan Medical Device Second Opinion Market.

Medical Device Second Opinion Market Type Outlook Insights

The Japan Medical Device Second Opinion Market showcases significant growth prospects across various sectors, particularly in the Type Outlook segment. Hospitals and Physicians/play crucial roles, as they are primary points for patient referrals seeking additional evaluations on medical diagnoses, thereby enhancing patient confidence and outcomes. The Online Physicians Portal has emerged as a vital platform in this segment, offering convenient access to specialists and streamlining the consultation process, which is paramount in Japan's tech-savvy society.Medical Second Opinion Companies are gaining traction by providing expert reviews and consultations to patients, ensuring they receive optimal care tailored to their conditions. Meanwhile, Health Insurance Companies increasingly recognize the value of second opinions in managing treatment costs effectively, aiming to prevent unnecessary procedures and improve patient satisfaction. This interconnected landscape of care represents a substantial portion of the market, reflecting evolving dynamics in healthcare consumption and the greater emphasis on patient-centered approaches.The overall structure indicates a robust framework aimed at delivering quality medical insights, contributing to the Japan Medical Device Second Opinion Market's dynamics in creating a well-informed patient base.

Japan Medical Device Second Opinion Market Key Players and Competitive Insights

The Japan Medical Device Second Opinion Market is characterized by a rapidly evolving landscape featuring various players that contribute to advancements in healthcare technology. This market thrives due to increasing healthcare awareness among consumers, digital transformation within the healthcare sector, and the growing demand for accurate and reliable medical diagnostics. The competitive insights reveal a blend of local prowess and international innovation as companies strive to enhance their offerings and meet stringent regulatory requirements. As the population ages and the prevalence of chronic diseases rises, the need for sophisticated medical devices capable of providing second opinions has also intensified, prompting an array of strategic partnerships, product launches, and technological advancements among key market players.

Siemens Healthineers has established a reputable presence in the Japan Medical Device Second Opinion Market, demonstrating significant strengths through its high-quality imaging and diagnostic solutions. The company’s innovative technologies not only contribute to improved patient outcomes but also enhance the efficiency of healthcare providers. Siemens Healthineers benefits from strong brand recognition within Japan, bolstered by its commitment to research and development that caters specifically to the needs of the local market. Strategic collaborations with Japanese healthcare institutions enable Siemens Healthineers to tailor its offerings, while its global expertise allows it to introduce cutting-edge technologies that align with Japan’s stringent health regulations and patient care standards.Terumo, as a key player in the Japan Medical Device Second Opinion Market, showcases a diverse range of products and services that are vital for delivering enhanced patient care. 

The company's outstanding strengths lie in its extensive portfolio encompassing vascular interventions, cardiac care, and transfusion medicine. Terumo has a firmly established market presence backed by a reputation for reliability and innovation. Its investment in research and development continues to yield robust solutions that address contemporary healthcare challenges. Terumo has also engaged in strategic mergers and acquisitions aimed at expanding its reach and enhancing its technological capabilities within Japan. This proactive approach not only fortifies its competitive standing but also reinforces its dedication to supporting healthcare practitioners in delivering accurate diagnoses and effective treatment pathways for patients in the region.

Key Companies in the Japan Medical Device Second Opinion Market Include:

• Siemens Healthineers


• Terumo


• Philips Healthcare


• Canon Medical Systems


• SHIMADZU


• Fujifilm


• Roche Diagnostics


• GE Healthcare


• Hitachi Medical Systems


• Nipro


• Asahi Kasei Medical


• Mitsubishi Electric


• Olympus


• Mizuho Medical

Japan Medical Device Second Opinion Market Industry Developments

Recent developments in the Japan Medical Device Second Opinion Market indicate a growing emphasis on advanced imaging and diagnostic technologies. Companies such as Siemens Healthineers and GE Healthcare continue to innovate, enhancing their offerings in medical imaging to support second opinions in critical healthcare decisions. In September 2023, Fujifilm announced a partnership with Terumo aimed at integrating their diagnostic tools to improve patient outcomes and streamline second opinions across medical facilities in Japan. Additionally, Olympus is advancing its endoscope technology to facilitate easier second-opinion consultations for gastrointestinal issues. In terms of market dynamics, Roche Diagnostics noted a significant increase in demand for second opinion services due to rising awareness about patient-centered care. Mergers within the sector include Canon Medical Systems acquiring certain assets of a smaller diagnostics firm in May 2023 to bolster its portfolio. This activity reflects ongoing consolidation in the market, with companies like Mitsubishi Electric and Hitachi Medical Systems actively looking for strategic partnerships to broaden their technological capabilities. Overall, these developments position Japan’s medical device sector for robust growth as advanced diagnostics become integral to healthcare delivery.

Japan Medical Device Second Opinion Market Segmentation Insights

Japan Medical Device Second Opinion Market Application Outlook

• Cancer


• Diabetes


• Cardiac Disorders


• Neurological Disorders


• Respiratory Disorders


• Ocular Disorders

Japan Medical Device Second Opinion Market Source of Service Outlook

• In-House


• Outsourced

Japan Medical Device Second Opinion Market Services Outlook

• Medical Condition Management


• Post-Acute Care Nursing


• Medical Peer Review Services

Japan Medical Device Second Opinion Market Type Outlook

• Hospitals Physicians/Specialties


• Online Physicians Portal


• Medical Second Opinion Companies


• Health Insurance Companies

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	0.18(USD Billion)
MARKET SIZE 2024	0.21(USD Billion)
MARKET SIZE 2035	0.92(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	14.31% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Siemens Healthineers, Terumo, Philips Healthcare, Canon Medical Systems, SHIMADZU, Fujifilm, Roche Diagnostics, GE Healthcare, Hitachi Medical Systems, Nipro, Asahi Kasei Medical, Mitsubishi Electric, Olympus, Mizuho Medical
SEGMENTS COVERED	Application Outlook, Source of Service Outlook, Services Outlook, Type Outlook
KEY MARKET OPPORTUNITIES	Telemedicine integration, Growing aging population, Rising chronic diseases, Increased healthcare spending, Demand for personalized care
KEY MARKET DYNAMICS	increasing patient awareness, technological advancements, regulatory challenges, competitive landscape, rising healthcare costs
COUNTRIES COVERED	Japan